Acute aluminium phosphide poisoning: Can we predict mortality?

Ashu Mathai1, Madhurita Singh Bhanu

  • 1Department of Anaesthesiology & Critical Care, Christian Medical College and Hospital, Ludhiana, Punjab, India.

Insights

Acute aluminium phosphide poisoning (AAlPP) in India has a high mortality rate, primarily due to early hemodynamic failure. Key predictors of mortality include low pH, elevated creatinine, and need for mechanical ventilation.

Area of Science:

  • Toxicology
  • Critical Care Medicine
  • Public Health

Background:

  • Acute aluminium phosphide poisoning (AAlPP) is a significant public health concern in India.
  • High mortality rates associated with AAlPP necessitate identification of risk factors for timely intervention.

Purpose of the Study:

  • To characterize AAlPP cases admitted to the ICU.
  • To identify predictors of mortality at the time of patient admission.

Main Methods:

  • A prospective study of 27 consecutive AAlPP patients admitted to the ICU.
  • Collection and comparison of 38 parameters at admission between survivor and non-survivor groups.

Main Results:

  • Overall mortality rate was 59.3%.
  • Significant mortality predictors included serum creatinine >1.0 mg%, pH <7.2, serum bicarbonate <15 mmol/L, need for mechanical ventilation, vasoactive drugs, and low APACHE II score.
  • Hypotension (89%) and ECG abnormalities (48.1%) were common on admission.

Conclusions:

  • AAlPP is associated with high mortality, largely driven by early hemodynamic compromise and multi-organ dysfunction.
  • Admission parameters like low pH, elevated creatinine, and need for critical care support are crucial indicators of poor prognosis in AAlPP.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...